Literature DB >> 26661328

Genetic and clinical analysis of spinocerebellar ataxia type 36 in Mainland China.

S Zeng1, J Zeng1, M He1, X Zeng1, Y Zhou1, Z Liu1, K Xia2, Q Pan2, H Jiang1,2,3, L Shen1,2,3, X Yan1, B Tang1,2,3, J Wang1,2,3.   

Abstract

Spinocerebellar ataxia type 36 (SCA36) is a new SCA subtype recently reported in Japanese and Spanish pedigrees. To assess the frequency and clinical characteristics of SCA36 in patients from Mainland China, we combined the repeat-primed polymerase chain reaction method and Southern blot analysis to detect the GGCCTG hexanucleotide repeats of NOP56 in 364 probands with SCA, 126 probands with hereditary spastic paraplegia and 99 probands with amyotrophic lateral sclerosis (ALS). Systematic and targeted clinical evaluations and investigations were conducted in the SCA36 patients. As a result, eight autosomal dominant spinocerebellar ataxia (ADCA) pedigrees (a total of 13 patients) and one sporadic SCA (S-SCA) patient were identified as SCA36 in the SCA cohort, accounting for approximately 1.60% of the cases in the ADCA group and 0.32% of those in the S-SCA group in Mainland China. The characteristics include late onset and slow progression accompanied by acoustic impairments and 'possible' ALS phenotype in patients from Mainland China.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NOP56; SCA36; Southern blot; hexanucleotide repeat expansion; repeat-primed PCR

Mesh:

Substances:

Year:  2016        PMID: 26661328     DOI: 10.1111/cge.12706

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

1.  Chimeric Peptide Species Contribute to Divergent Dipeptide Repeat Pathology in c9ALS/FTD and SCA36.

Authors:  Zachary T McEachin; Tania F Gendron; Nisha Raj; María García-Murias; Anwesha Banerjee; Ryan H Purcell; Patricia J Ward; Tiffany W Todd; Megan E Merritt-Garza; Karen Jansen-West; Chadwick M Hales; Tania García-Sobrino; Beatriz Quintáns; Christopher J Holler; Georgia Taylor; Beatriz San Millán; Susana Teijeira; Toru Yamashita; Ryuichi Ohkubo; Nicholas M Boulis; Chongchong Xu; Zhexing Wen; Nathalie Streichenberger; Brent L Fogel; Thomas Kukar; Koji Abe; Dennis W Dickson; Manuel Arias; Jonathan D Glass; Jie Jiang; Malú G Tansey; María-Jesús Sobrido; Leonard Petrucelli; Wilfried Rossoll; Gary J Bassell
Journal:  Neuron       Date:  2020-05-05       Impact factor: 17.173

2.  The Clinical and Polynucleotide Repeat Expansion Analysis of ATXN2, NOP56, AR and C9orf72 in Patients With ALS From Mainland China.

Authors:  Xiaorong Hou; Wanzhen Li; Pan Liu; Zhen Liu; Yanchun Yuan; Jie Ni; Lu Shen; Beisha Tang; Junling Wang
Journal:  Front Neurol       Date:  2022-05-06       Impact factor: 4.086

3.  Antisense Oligonucleotides Reduce RNA Foci in Spinocerebellar Ataxia 36 Patient iPSCs.

Authors:  Kosuke Matsuzono; Keiko Imamura; Nagahisa Murakami; Kayoko Tsukita; Takuya Yamamoto; Yuishin Izumi; Ryuji Kaji; Yasuyuki Ohta; Toru Yamashita; Koji Abe; Haruhisa Inoue
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-23       Impact factor: 8.886

Review 4.  Spinocerebellar Ataxia 36: From Mutations Toward Therapies.

Authors:  Samuel Lopez; Fang He
Journal:  Front Genet       Date:  2022-03-04       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.